Diagnosis, Workup, Risk Reduction of Transient Ischemic Attack in the Emergency Department Setting:A Scientific Statement From the American HEart Association
Stroke 54:e109-e121, Hardik,P.A.,et al, 2023
Guidelines in Action: Worse Headache of Life...Yesterday
Stroke 54:e488-e491, Albin,C.S.W., 2023
Clinicopathologic Conference, Seizure from Neurocysticercosis
NEJM 385:1894-1902, Case 34-2021, 2021
Determination of Brain Death
NEJM 385:2554-2561, Greer, D.M., 2021
Transient Ischemic Attack
NEJM 382:1933-1941, Amarenco, P., 2020
Mechanical Thrombectomy in the Era of the COVID-19 Pandemic: Emergency Preparedness for Neuroscience Teams
Stroke 51:1896-1901, Nguyen, T.N.,et al, 2020
Distal Symmetric Polyneuropathy in 2020
JAMA 324:90-92, Callaghan, B.C.,et al, 2020
Anosmia and Loss of Smell in the Era of COVID-19
BMJ 370:m2808, Walker, A.,et al, 2020
Primary Thrombectomy in tPA (Tissue-Type Plasminogen Activator) Eligible Stroke Patients with Proximal Intracranial Occlusions
Stroke 49:265-269, Fischer, U.,et al, 2018
Management of Acute Retinal Ischemia
Ophthalmol 125:1597-1607, Viousse, V.,et al, 2018
Autoimmune Encephalitides: A Broadening Field of Treatable Conditions
Neurologist 22:1-13, Kalman, B., 2017
Interim Results from the CATNON trial (EORTC study 260-53-22054) of treatment with Concurrent and Adjuvant Temozolomide for 1p/19q non-co-deleted anaplastic glioma: A phase 3, randomized, open-label intergroup study
Lancet 390:1645-1653, Van Den Bent, M.J.,et al, 2017
Anal Carcinoma
NCCN.org April 2017 V2.2017, , 2017
Cryptogenic Stroke
NEJM 374:2065-2074, Saver, J.L., 2016
Stroke Outcomes with use of Antithrombotics within 24 hours after Recanalization Treatment
Neurol 87:996-1002, Jeong, H.G.,et al, 2016
Myasthenia Gravis
NEJM 375:2570-2581, Gilhus, N.E.,et al, 2016
Stroke Prevention in Atrial Fibrillation
JAMA 313:1950-1962, Lip, G.Y.H. & Lane, D.A., 2015
HIV Testing and Management of Newly Diagnosed HIV
BMJ 349:g4275, Rayment, M.,et al, 2014
Patent Foramen Ovale and Cryptogenic Stroke
Stroke 44:2676-2678, Furlan, A.J. and Jauss, M., 2013
Carotid Stenosis
NEJM 369:1143-1150, Grotta, J., 2013
Predictors of Rapid Brain Imaging in Acute Stroke
Stroke 43:1279-1284, Kelly,A.G.,et al, 2012
Acute Stroke Imaging: What is Sufficient for Triage to Endovascular Therapies?
AJNR 33:790-792, Lev, M.H., 2012
The Management of Suspected Encephalitis
BMJ 344:e3489, Thwaites, G.E., 2012
Evidence-based Guideline: Diagnostic accuracy of CSF 14-3-3 Protein in Sporadic Creutzfeldt-Jakob Disease
Neurol 79:1499-1506, Muayqil, T.,et al, 2012
Diagnosis and Management of Cerebral Venous Thrombosis: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
Stroke 42:1158-1192, Saposnik,G.,et al, 2011
Metastatic spinal cord compression
BMJ 342:d2402, Quraishi, N. & Esler, C., 2011
Mild Cognitive Impairment
NEJM 362:2227-2234, Peterson, R.C., 2011
An Update on Brain Death Criteria A Simple Algorithm with Complex Questions
The Neurologist 17-237-240, Scripko, P.D.,et al, 2011
Evidence-based Guideline: Clinical Evaluation and Treatment of Transverse Myelitis
Neurol 77:2128-2134, Scott, T.F.,et al, 2011
Should TIA Patients Be Hospitalized or Referred to a Same-Day Clinic?
Neurol 77-2082-2088, Joshi, J.K.,et al, 2011
Prolactinomas
NEJM 362:1219-1226, Klibanski,A., 2010
Natalizumab and Progressive Multifocal Leukoencephalopathy: What are the Causal Factors and Can It be Avoided?
Arch Neurol 67:923-930, Warnke,C., et al, 2010
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
Stroke 41:2108-2129, Morgenstern,L.B.,et al, 2010
A Diagnostic and Therapeutic Scheme for a Solitary Cysticercus Granuloma
Neurol 75:2236-2245, Singh,G.,et al, 2010
Genetic Aspects of Alzheimer Disease
The Neurologist 15:80-86, Williamson,J.,et al, 2009
Diagnosis and Management of Neuropathic Pain
BMJ 339:391-395, Freynhagen,R. &Bennett,M.I., 2009
Practice Parameter: Evaluation of the Child with Microcephaly (An Evidence-Based Review): Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society
Neurol 73:887-897, Ashwal,S.,et al, 2009
Best Practice Recommendations for the Selection and Management of Patients with Multiple Sclerosis Receiving Natalizumab Therapy
Mutliple Sclerosis 15:S26-S36, Coyle,P.K.,et al, 2009
Management of Patients With Head Injury
Lancet 372:685-687, Mendelow,A.D.,et al., 2008
Diagnosis and Management of Patients at Risk of or with Metastatic Spinal Cord Compression: Summary of NICE Guidance
BMJ 337:1349-1351, White,B.D.,et al, 2008
The Management of Encephalitis: Clinical Practice Guidelines by the Infectious Disease Society of America
Clinical Infectious Diseases 47:303-327, Tunkel, A.R.,et al, 2008
Natalizumab for Multiple Sclerosis
NEJM 356:2622-2629, Ransohoff,R.M., 2007
Natalizumab (Tysabri) Treatment for Relapsing Multiple Sclerosis
The Neurologist 13:182-187, Johnson,K.P., 2007
Prophylactic Cranial Irradiation in Extensive Small-Cell Lung Cancer
NEJM 356:664-672, Slotman,B.,et al, 2007
Implementation Strategies for Emergency Medical Services Within Stroke Systems of Care: A Policy Statement From the American Heart Association/American Stroke Association Expert Panel on Emergency Medical Services Systems and the Stroke Council
Stroke 116:3097-3115, Acker,J.E. III,et al, 2007
The Tuberous Sclerosis Complex
NEJM 355:1345-1356, Crino,P.B.,et al, 2006
Patterns of Care for Adults With Newly Diagnosed Malignant Glioma
JAMA 293:557-564,615, Chang,S.M.,et al, 2005
Rehabilitation After Stroke
NEJM 352:1677-1684, Dobkin,B.H., 2005
Recommended Diagnostic Criteria for Paraneoplastic Neurological Syndromes
JNNP 75:1135-1140,1090, Graus,F.,et al, 2004